Tandlæge Nina Johansen ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  0.0% 1.8% 1.3% 1.2% 2.2%  
Credit score (0-100)  0 72 80 82 64  
Credit rating  N/A A A A BBB  
Credit limit (kDKK)  0.0 0.7 22.1 38.6 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  0.0 3,761 3,705 3,670 3,905  
EBITDA  0.0 514 406 367 -59.9  
EBIT  0.0 382 279 237 -190  
Pre-tax profit (PTP)  0.0 326.0 262.0 213.0 -238.1  
Net earnings  0.0 254.0 204.0 165.0 -186.7  
Pre-tax profit without non-rec. items  0.0 326 262 213 -238  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  0.0 631 562 492 420  
Shareholders equity total  0.0 294 385 550 245  
Interest-bearing liabilities  0.0 1,231 1,142 756 1,035  
Balance sheet total (assets)  0.0 2,539 2,149 1,913 1,752  

Net Debt  0.0 1,116 1,140 750 1,018  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 3,761 3,705 3,670 3,905  
Gross profit growth  0.0% 0.0% -1.5% -0.9% 6.4%  
Employees  0 6 6 5 7  
Employee growth %  0.0% 0.0% 0.0% -16.7% 40.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 2,539 2,149 1,913 1,752  
Balance sheet change%  0.0% 0.0% -15.4% -11.0% -8.4%  
Added value  0.0 514.0 406.0 364.0 -59.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 1,639 -256 -260 -262  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 3.0 -1.0  

Profitability 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 10.2% 7.5% 6.5% -4.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 15.6% 12.7% 12.6% -10.0%  
ROI %  0.0% 24.9% 18.6% 16.9% -13.2%  
ROE %  0.0% 86.4% 60.1% 35.3% -47.0%  

Solidity 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  0.0% 11.6% 17.9% 28.8% 14.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 217.1% 280.8% 204.4% -1,699.1%  
Gearing %  0.0% 418.7% 296.6% 137.5% 423.1%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 11.4% 2.9% 4.5% 6.2%  

Liquidity 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.0 0.6 0.4 0.4 0.2  
Current Ratio  0.0 0.7 0.6 0.6 0.3  
Cash and cash equivalent  0.0 115.0 2.0 6.0 17.2  

Capital use efficiency 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -262.0 -405.0 -294.0 -723.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 86 68 73 -9  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 86 68 73 -9  
EBIT / employee  0 64 47 47 -27  
Net earnings / employee  0 42 34 33 -27